Tag: mRNA

Moderna
Pharmaceuticals & Biotechnology
USA

Valuation Analysis: Moderna

Moderna strengthens its mRNA platform with positive Phase 3 data in oncology and the approval of MFLUSIVA; however, financial risks
Continue Umbrella
Moderna
Pharmaceuticals & Biotechnology
USA

Stock: Moderna, Inc.

Moderna strengthens its mRNA platform with positive Phase 3 data in oncology and the approval of MFLUSIVA; however, financial risks
Continue Umbrella